1M Performance - Absolute: During April'25 (1M period), the KBCS Holdings Universe posted a return of +2.7% which was mainly driven by multi-asset holdings (+3.0%) while single-asset holdings posted a smaller return of +2.0%. The 3 top performers during the period were D'Ieteren (+10.6%), Ackermans & van Haaren (+7.7%) and Groupe Bruxelles Lambert (+5.4%) while the 3 worst performers were Exor (-0.8%), HAL Trust (-1.5%) and Quest for Growth (-5.5%). YTD Performance - Relative: On a YTD basis (a...
Exor announced the results of its €1 billion tender offer which is part of a broader share buyback program. The reverse Dutch auction, which closed on April 23, 2025, saw 22,965,749 ordinary shares tendered by qualifying shareholders. Due to oversubscription, Exor purchased 12,254,495 shares (5.5% of issued shares) at a strike price of €81.6 per share, reflecting a 2% premium over the reference volume-weighted average price (VWAP) of €80.0, and a 1.8% premium over yesterday's close at €80.2. The...
Allfunds Group plc: 1Q25 Preview. Azelis: 1Q25 EBITA miss on tariff uncertainty, €20m self-help to support margins. Exor: Announces oversubscribed €1bn SBB tender offer, strike at VWAP +2%. Flow Traders: Mike drop. Fugro: 1Q25 as expected but outlook a question mark. IMCD: Breaking with tradition: CEO gone within 15 months. Kinepolis: Weak 1Q25, offset by a strong 2Q25 start. KPN: Small 1Q25 EBITDAal beat, guidance reiterated. Randstad: Capital Markets Event. RELX: 1Q25 trading...
Exor Press Release - Tender Offer Result THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 24 April 2025 EXOR ANNOUNCES OVERSUBSCRIBED TENDER OFFER, AS PART OF €1 BILLION SHARE BUYBACK PROGRAM Exor N.V. (“Exor” or the “Company”) announces the results of the Tender Offer set out in the Offer Memorandum published by the Company on 26 March 2025 (the “Offer Memorandum”). ...
Exor Press Release - Announcement of the Reference VWAP for the Tender Offer THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 17 April 2025 EXOR N.V.: ANNOUNCEMENT OF THE REFERENCE VWAP FOR THE TENDER OFFER On 17 April 2025, the reported closing price of the Ordinary Shares on Euronext Amsterdam was EUR 78.30 per Ordinary Share. The volume weighted average market pri...
Exor Press Release - Karl Guha Nomination Amsterdam, 10 April 2025 ING CHAIRMAN KARL GUHA NOMINATED TO JOIN EXOR BOARD Exor nominates ING Chairman Karl Guha as a non-executive member of its Board of Directors, subject to approval at the Company’s next Annual General Meeting on 22 May 2025. Karl is an international banker with over three decades of experience across the United States, Europe, Australia and Asia. He began his career at ABN Amro in 1989, holding various executive roles. He then served as Group Chief Risk Officer of Unicredit (2008-2013) and Chairman of the Managing Board...
After the successful sale of 7m Ferrari shares for a total consideration of €3bn and taking into account Exor's €1bn share buyback (SBB), the rest of the proceeds are to be used to pursue diversification into the healthcare, luxury and technology sectors. This will balance the cyclical profile of Stellantis and CNHi (together 21% of NAV) and the overweight in Ferrari (43% of NAV). We see the upcoming investment as a catalyst for the stock considering its impressive track record while potential o...
Trumps reciprocal tariffs caused a massive blow to equity markets, following a pressured period of escalating trade wars. Retaliatory measures can further heavily damage market confidence, as seen Friday when China announced their 34% tarrif of US goods. International trade policies have never moved this erratic and untransparant, with uncertainty and volatility being the baseline for now. In this report we highlight the key stocks in our coverage relevant to this discussion.
Arcadis: Large contract in Resilience. ASM International: Highlights from CFO roadshow. Exor: Exor buying back Exor shares. Fastned: 2H24 results, cost pressure. Flow Traders: February volumes elevated in EMEA. Montea: JV with Weerts in Belgium. Sligro: FY24 results in line, weak 1Q25 outlook. Sofina: Final NAV a tad higher. Umicore: CMD targets – no big bang
During FY24, NAV rose by 9% YoY to €38.2b or €178.8ps (KBCSe: €174.3ps). This was mainly driven by the rally in Ferrari (35%+) and Philips (16%+). Exor has been diversifying its portfolio away from Ferrari, its single biggest position, which currently makes up ~40% of NAV. During FY24, Exor increased its stake in Philips to 18.7%, acquired a 10.1% stake in Clarivate, increased stake in Institut Mérieux to 10% and executed a €72m follow up investment in TagHolding. Furthermore, during March'25, E...
Exor Press Release - Tender Offer Launch THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 26 March 2025 EXOR ANNOUNCES THE LAUNCH OF A TENDER OFFER TO REPURCHASE UP TO €1 BILLION IN ORDINARY SHARES Exor N.V. (“Exor” or the “Company”) announces the launch of a tender offer to purchase ordinary shares with a nominal value of EUR 0.01 each in the share capital of Exor N...
Exor Press Release - FY24 Results Amsterdam, 26 March 2025 EXOR DELIVERS 9% NAV PER SHARE GROWTH IN 2024 LAUNCH OF A €1 BILLION SHARE BUYBACK PROGRAM WITH TENDER OFFER AT UP TO 10% PREMIUM NAV reached €38.2 billion at 31 December 2024, with NAV per share increasing by 9%Strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. Active and disciplined capital allocation with increased exposure to Healthcare Ordinary dividend to be distributed of approximately €100 million, subject to AGM approvalLaunch of a new €1 billion sh...
1M Performance - Absolute: During Feb'25 (1M period), the KBCS Holdings Universe posted a return of +3.7% which was mainly driven by single-asset holdings (+11.1%) while multi-asset holdings posted a modest return of +0.5%. The 3 top performers during the period were Heineken Holding (+21.3%), KBC Ancora (+6.9%) and Ackermans & van Haaren (+4.4%) while the 3 worst performers were Financière de Tubize (-6.3%), Compagnie du Bois Sauvage (TINC; -6.6%) and Whitestone Group (-6.8%). YTD Performance...
Exor announced that it will sell ~6.7m common shares (3.61% of total shares) of Ferrari, via an accelerated bookbuild offering to institutional investors, for total proceeds of ~€3.0b. The shares are being offered at €450.0ps and the transaction is expected to be completed by 3rd March'25. Post transaction, Exor's stake in Ferrari will decline from 22.91% to 19.47%. Exor guided that the proceeds will be used to introduce a new investment withing the portfolio and execute a €1.0b SBB program. Whi...
Aalberts: Dividend and outlook better than expected. Ackermans & van Haaren: Anticipating an all-time-high result from core segments. Ageas: FY24 in line, strong capital, outlook for upsteams. AMG: Strong 4Q24 beat and 2025F guidance upgrade. CFE: Solid results and balance sheet, outlook weak. CMB.TECH: Cautious on outlook. Corbion: Not so sweet. CTP: Good results, 2025 outlook realistic. D'Ieteren: Boyd's Five-Year Goals. Exor: Ferrari €3bn ABB and €1bn SBB. Sofina: Further ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.